Heptares Attracts $21m for Clinical Development
Drug discovery and development company Heptares Therapeutics has raised over $21 million in a Series B financing. The round was co-led by the Stanley Family Foundation and current investor Clarus Ventures with Takeda Ventures also participating.
27 June 2013•6 mins read
